MIR5009

Across TCGA pan-cancer cohorts, MIR5009 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR5009’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR5009 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR5009 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

LUSC and KICH are the cancer types where MIR5009 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5009 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	II,III,IV	−0.464	.017	2	view →
KICH	All	II,III,IV	+0.178	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MIR5009–LUSC

Open the LUSC breakdown →